EXEL vs SYK
Exelixis vs Stryker Corporation — AI-powered side-by-side comparison
VS
SYK
Stryker Corporation
59
Buy
| Metric | EXEL | SYK |
|---|
| AI Score |
67
|
59
|
| Price |
$56.58
|
$330.05
|
| P/E Ratio |
17.24×
|
33.98×
|
| ROE |
36.2%
|
14.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
96.5%
|
65.2%
|
| Debt / Equity |
0.09×
|
0.62×
|
| Dividend Yield |
0.0%
|
1.1%
|
| RSI (14) |
69.6
|
44.6
|
| Beta |
0.422
|
0.771
|
| Expected Upside |
+1.4%
|
+13.1%
|
AI Committee View
Current Innellis committee reasoning for EXEL versus SYK.
EXEL leads by 8 points.
EXEL scores 67/100 (Buy) versus SYK at 59/100 (Buy).
EXEL Committee View
83% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- P/E of 14.5 is inexpensive for the broad market — Value
- ROE of 42.5% shows genuine earnings power backing the valuation — Value
- EPS growing 52.7% YoY — Growth
Bear Case
- Price-to-book of 5.4x prices in significant intangible value — Value
SYK Committee View
60% agreement
5 analysts
Positive signals support the current rating — eps growing 27.7% yoy. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- ROE of 16.4% shows genuine earnings power backing the valuation — Value
- EPS growing 27.7% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 35.2 is moderate-to-rich — Value
- Price-to-book of 6.0x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical